{
  "CitationSubset": [],
  "KeywordList": [
    [
      "cancer cure",
      "cancer survivors",
      "life expectancy",
      "time to cure"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "31436897",
  "DateCompleted": {
    "Year": "2020",
    "Month": "04",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "04",
    "Day": "22"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2019",
        "Month": "08",
        "Day": "22"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1111/ecc.13139"
    ],
    "Journal": {
      "ISSN": "1365-2354",
      "JournalIssue": {
        "Volume": "28",
        "Issue": "6",
        "PubDate": {
          "Year": "2019",
          "Month": "Nov"
        }
      },
      "Title": "European journal of cancer care",
      "ISOAbbreviation": "Eur J Cancer Care (Engl)"
    },
    "ArticleTitle": "Major patterns of cancer cure: Clinical implications.",
    "Pagination": {
      "StartPage": "e13139",
      "MedlinePgn": "e13139"
    },
    "Abstract": {
      "AbstractText": [
        "This review aimed to classify major patterns of cancer cure and discuss clinical implications. Patterns of cancer cure were identified, in terms of long-term survival and life expectancy, by means of two recently estimated indicators: cure fraction (CF) and time to cure (TTC).",
        "We considered population-based studies reporting results for some cancer types on CF, defined as the proportion of patients who will reach the same life expectancy of the general population, or/and TTC, the time span necessary to experience a negligible excess mortality. TTC\u00a0is obtained using conditional relative survival, which indicates the probability of surviving an additional y number of years, given that patients already survived x number of years.",
        "Four major patterns of cancer types emerged from published studies: (a) cancers with a CF\u00a0>\u00a060% and a TTC\u00a0<\u00a05\u00a0years (e.g., testicular, thyroid); (b) cancers with a CF between 20% and 50% and a TTC\u00a0<\u00a010\u00a0years (colon, rectum); (c) cancers showing a CF of approximately 50% and TTC\u00a0>\u00a010\u00a0years (breast, prostate and bladder); (d) cancers with a CF\u00a0<\u00a020% and uncertain TTC (lung or pancreas).",
        "Clinical and social impact of \"cancer cure\" categorisation are discussed in details. Recognising a cancer patient as cured represents an opportunity to improve their quality of life."
      ],
      "CopyrightInformation": "\u00a9 2019 John Wiley & Sons Ltd."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0003-0177-086X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Umberto I Hospital, Siracusa, Italy."
          }
        ],
        "LastName": "Tralongo",
        "ForeName": "Paolo",
        "Initials": "P"
      },
      {
        "Identifier": [
          "0000-0002-8685-4212"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "New York University Medical School, New York, NY, USA."
          }
        ],
        "LastName": "Surbone",
        "ForeName": "Antonella",
        "Initials": "A"
      },
      {
        "Identifier": [
          "0000-0003-0565-8920"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy."
          }
        ],
        "LastName": "Serraino",
        "ForeName": "Diego",
        "Initials": "D"
      },
      {
        "Identifier": [
          "0000-0001-6163-200X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy."
          }
        ],
        "LastName": "Dal Maso",
        "ForeName": "Luigino",
        "Initials": "L"
      }
    ],
    "GrantList": [
      {
        "GrantID": "16921",
        "Agency": "Italian Association for Cancer Research (AIRC)",
        "Country": ""
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Eur J Cancer Care (Engl)",
    "NlmUniqueID": "9301979",
    "ISSNLinking": "0961-5423"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cancer Survivors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Life Expectancy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "epidemiology",
        "mortality",
        "therapy"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Survival Rate"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    }
  ]
}